Buspirone Hcl
Brand name: Buspirone Hcl
Rank #241 of 500 drugs by total cost
$53.7M
Total Cost
2,868,147
Total Claims
$53.7M
Total Cost
61,219
Prescribers
$19
Cost per Claim
453,322
Beneficiaries
4,208,013
30-Day Fills
$877
Avg Cost/Provider
47
Avg Claims/Provider
About Buspirone Hcl
Buspirone Hcl (sold as Buspirone Hcl) was prescribed 2,868,147 times by 61,219 Medicare Part D providers in 2023, costing the program $53.7M. At $19 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 238 | Netarsudil Mesylat/Latanoprost (Rocklatan) | $54.7M | 103,171 |
| 239 | Amifampridine Phosphate (Firdapse) | $54.4M | 1,203 |
| 240 | Dapaglifloz Propaned/Metformin (Xigduo Xr) | $54.4M | 58,629 |
| 241 | Buspirone Hcl (Buspirone Hcl) | $53.7M | 2,868,147 |
| 242 | Oxybutynin Chloride (Oxybutynin Chloride Er) | $53.4M | 1,872,901 |
| 243 | Raltegravir Potassium (Isentress) | $53.0M | 25,491 |
| 244 | Belumosudil Mesylate (Rezurock) | $52.3M | 2,280 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology